2017 has been a fantastic year for Kids v Cancer.
This year, the U.S. Congress passed our RACE for Children Act, requiring companies developing cancer targeted therapies for adults to also develop the drugs for children.
The impact of RACE for Children Act will be profound. continue reading →
A video on how Kids v Cancer is creating incentives and requirements for companies to undertake pediatric studies. more→
Taken together, the RACE for Children Act and the Pediatric PRV program change the landscape of pediatric cancer research. more→
The RACE for Children Act became law, ensuring that novel and exciting new cancer drugs will now be developed not only for adults, but also for children with cancer. more→
What are the Priority Review Vouchers and how do they benefit the society? more→
The Research to Accelerate Cures and Equity for Children (RACE) Act will close loopholes in U.S. drug approval guidelines that companies have exploited to avoid enrolling children in clinical cancer research. more→